To further determine the mechanisms through which SHP-1 suppresses breast cancer, we focused on EGFR and members of its major downstream signaling pathway to investigate whether they might be responsible for the suppressed proliferation and invasion induced by SHP-1. Here, PTPN6 is linked to breast carcinoma.